Illumina

Meet the MiSeq i100 Series – the new standard in sequencing simplicity with a 3-step setup, onboard DRAGEN analysis, and same-day results to accelerate genomic discovery and insights: https://bit.ly/4eTqugz

Congratulations to ISABEL CRISTINA CESPEDES at Unifesp - Universidade Federal de São Paulo, winner of the 2024 Illumina Epigenetics Research Grant Contest. The award enables researchers to deepen their understanding of human disease with the Illumina Infinium Methylation Screening Array. Céspedes hopes to take the first-ever molecular approach to studying the unwanted effects of blood transfusions.

Here are six reasons to utilize our accurate data analysis tools to revolutionize your research.

Every breakthrough at Illumina starts with a team of people driven by a shared mission: unlock the power of the genome to improve human health for all. Hear from a few of our team members as to why they’re inspired to make a difference and come to work every day. #IlluminaProud #Genomics4All

Dyno Therapeutics needed a sequencing tool that could support the complexity and scale of their AI modeling. Eric Kelsic and Ben Noyes share how the NextSeq 2000 helps them push their work to new heights, delivering the scalability and reliability they need.

With a unique background in chemical engineering, biochemistry and clean energy, Associate Director of Scientific Research Erin Imsand and her team developed our first-ever product to use lyophilization for room-temperature reagent storage. This breakthrough makes genomic sequencing more accessible and sustainable than ever—no freezers or refrigerators needed! 👏 Now, researchers worldwide can benefit from simplified workflows, less reliance on cold storage and more time to devote towards scientific breakthroughs with the MiSeq i100 Series. Read about Erin and her team’s game-changing work: https://bit.ly/3ZNy5sl #IlluminaProud

The MiSeq i100 is now shipping globally, and we're excited to share that it has made its European debut at Functional Genomics Center Zurich with Catharine and team! #IlluminaProud

The Tohoku Medical Megabank Organization (ToMMo) is pushing the boundaries of precision medicine in Japan by linking comprehensive health data with advanced genetic insight to understand dementia, rare diseases and more. Powered by Illumina technology, the population genomics project recently reached a major milestone – 100,000 genomes sequenced – on its path to sequencing 150,000! This work is crucial for advancing global genomics, diversifying sequencing data and developing more personalized care. Learn how the ToMMo Project is driving change in genomics and precision medicine. #Genomics4All Tohoku University

Just how simple is the MiSeq i100 Series to use? Sireesha Lujan, Global Training & Development Scientist, will show you!

We’re excited to share that we have ranked #3 on Newsweek's 2025 list of America’s Most Responsible Companies! This recognition is a reflection of our commitment to deepen our impact on human health by serving as a champion for our customers, our communities, our people, and our planet.